Literature DB >> 3077943

Marrow stromal stem cells.

M Owen1.   

Abstract

Evidence for the hypothesis that there are stromal stem cells present in the soft connective tissues associated with marrow and bone surfaces that are able to give rise to a number of different cell lines is reviewed. The lines are currently designated fibroblastic, reticular, adipocytic and osteogenic. Fibroblastic colonies, each derived from a single colony-forming unit fibroblastic (CFU-F), are formed when marrow cells are cultured in vitro. In vivo assays of tissue formed by CFU-F in open transplant or in diffusion chambers, have demonstrated that some CFU-F have a high ability for self renewal and multipotentiality whereas some have more limited potential. Preliminary investigations in vitro also support the hypothesis and have shown that CFU-F are a heterogeneous population of stem and progenitor cells and that their differentiation in vitro can be modified at the colony level. The stromal cells which survive and proliferate in vitro are highly dependent on culture conditions. The number and hierarchy of cell lines belonging to the stromal fibroblastic system are not yet fully elucidated and more specific markers and better assays for the different phenotypes are required before a greater understanding can be achieved. The possibility that the marrow stromal system is part of a wider stromal cell system of the body is proposed.

Mesh:

Year:  1988        PMID: 3077943     DOI: 10.1242/jcs.1988.supplement_10.5

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  138 in total

1.  Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy.

Authors:  Z Hou; Q Nguyen; B Frenkel; S K Nilsson; M Milne; A J van Wijnen; J L Stein; P Quesenberry; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  Mesenchymal stem cells. A potential source for skeletal repair.

Authors:  W E Fibbe
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 3.  Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

Authors:  Todd Meyerrose; Scott Olson; Suzanne Pontow; Stefanos Kalomoiris; Yunjoon Jung; Geralyn Annett; Gerhard Bauer; Jan A Nolta
Journal:  Adv Drug Deliv Rev       Date:  2010-10-13       Impact factor: 15.470

4.  Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells.

Authors:  Yukinori Akiyama; Christine Radtke; Jeffery D Kocsis
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

5.  In vitro study of the differentiation of bone marrow stromal cells into cardiomyocyte-like cells.

Authors:  Karimeh Haghani; Salar Bakhtiyari; Ali Mohammad Nouri
Journal:  Mol Cell Biochem       Date:  2011-10-19       Impact factor: 3.396

6.  Subcutaneous adipocytes may become osteoblasts.

Authors:  Simone Ciuffi; Sergio Fabbri; Roberto Zonefrati; Gianna Galli; Annalisa Tanini; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

Review 7.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

8.  Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka.

Authors:  Philippe Hernigou
Journal:  Int Orthop       Date:  2015-03-07       Impact factor: 3.075

Review 9.  [Bridging posttraumatic bony defects. Established and new methods].

Authors:  M Schieker; W Mutschler
Journal:  Unfallchirurg       Date:  2006-09       Impact factor: 1.000

10.  Vignacyanidin Polyphenols Isolated from Vigna Angularis Bean Promote Osteoblast Differentiation.

Authors:  Thira Rojasawasthien; Tomohiko Shirakawa; Ayako Washio; Toshiyuki Tsujisawa; Takuma Matsubara; Asako Inoue; Umeo Takahama; Keisuke Nakashima; Shoichiro Kokabu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.